The DOI matches its Crossref record; 768 of the 768 references it cites were found in a registry or an index.
Diabetic cardiomyopathy: Mechanisms and new treatment strategies targeting antioxidant signaling pathways
Open accessAbstract
Cardiovascular disease is the primary cause of morbidity and mortality among the diabetic population. Both experimental and clinical evidence suggest that diabetic subjects are predisposed to a distinct cardiomyopathy, independent of concomitant macro- and microvascular disorders. 'Diabetic cardiomyopathy' is characterized by early impairments in diastolic function, accompanied by the development of cardiomyocyte hypertrophy, myocardial fibrosis and cardiomyocyte apoptosis. The pathophysiology underlying diabetes-induced cardiac damage is complex and multifactorial, with elevated oxidative stress as a key contributor. We now review the current evidence of molecular disturbances present in the diabetic heart, and their role in the development of diabetes-induced impairments in myocardial function and structure. Our focus incorporates both the contribution of increased reactive oxygen species production and reduced antioxidant defenses to diabetic cardiomyopathy, together with modulation of protein signaling pathways and the emerging role of protein O-GlcNAcylation and miRNA dysregulation in the progression of diabetic heart disease. Lastly, we discuss both conventional and novel therapeutic approaches for the treatment of left ventricular dysfunction in diabetic patients, from inhibition of the renin-angiotensin-aldosterone-system, through recent evidence favoring supplementation of endogenous antioxidants for the treatment of diabetic cardiomyopathy. Novel therapeutic strategies, such as gene therapy targeting the phosphoinositide 3-kinase PI3K(p110α) signaling pathway, and miRNA dysregulation, are also reviewed. Targeting redox stress and protective protein signaling pathways may represent a future strategy for combating the ever-increasing incidence of heart failure in the diabetic population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 601–768 of 768
Faria, A. M., Papadimitriou, A., Silva, K. C., de Faria, J. M. L., & de Faria, J. B. L. (2012) · Diabetes · doi:10.2337/db11-1241 · Cited by 77
Diagnosis and management of diastolic dysfunction and heart failure.
Satpathy, C., Mishra, T. K., Satpathy, R., Satpathy, H. K., & Barone, E. J. (2006) · PubMed · Cited by 76
Role of ACE2 in diastolic and systolic heart failure
Wang, W., Bodiga, S., Das, S. K., Lo, J., Patel, V. B., & Oudit, G. Y. (2011) · Heart Failure Reviews · doi:10.1007/s10741-011-9259-x · Cited by 76
β-blockers in hypertension: is carvedilol different?
Messerli, F. H., & Grossman, E. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.01.020 · Cited by 76
Vahtola, E., Louhelainen, M., Merasto, S., Martonen, E., Penttinen, S., Aahos, I., Kytö, V., Virtanen, I., & Mervaala, E. M. A. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f293c8 · Cited by 76
Axelsen, L. N., Lademann, J. B., Petersen, J. S., Holstein‐Rathlou, N., Ploug, T., Prats, C., Pedersen, H. D., & Kjølbye, A. L. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00392.2009 · Cited by 76
Ishikawa, T., Kajiwara, H., & Kurihara, S. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.277.6.h2185 · Cited by 76
Potentiation of Bradykinin Actions by ACE Inhibitors
Erdös, E. G., Deddish, P. A., & Marcic, B. M. (1999) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(99)00156-3 · Cited by 75
Rodrigues, B. B., Goyal, R. K., & McNeill, J. H. (1986) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)25075-3 · Cited by 74
Connelly, K. A., Zhang, Y., Advani, A., Advani, S. L., Thai, K., Yuen, D. A., & Gilbert, R. E. (2012) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12005 · Cited by 74
Wittenstein, B., Klein, M. O., Finckh, B., Ullrich, K., & Kohlschütter, A. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00863-8 · Cited by 74
Vasanji, Z., Cantor, E. J. F., Juric, D., Moyen, M., & Netticadan, T. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00086.2005 · Cited by 74
Anfossi, G., Russo, I., Bonomo, K., & Trovati, M. (2010) · Current Vascular Pharmacology · doi:10.2174/157016110791112359 · Cited by 74
Perazella, M. A., & Setaro, J. F. (2003) · Journal of Nuclear Cardiology · doi:10.1067/mnc.2003.392 · Cited by 72
Targeting the redox regulation of SERCA in vascular physiology and disease
Tong, X., Evangelista, A. M., & Cohen, R. A. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.11.008 · Cited by 72
Alagiakrishnan, K., Banach, M., Jones, L. G., Datta, S., Ahmed, A., & Aronow, W. S. (2012) · Annals of Medicine · doi:10.3109/07853890.2012.660493 · Cited by 71
NADPH oxidase and heart failure
Murdoch, C. E., Grieve, D., Cave, A. C., Looi, Y. H., & Shah, A. M. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.10.008 · Cited by 71
Brower, G. L., Levick, S. P., & Janicki, J. S. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00447.2006 · Cited by 70
MicroRNA-133a regulates DNA methylation in diabetic cardiomyocytes
Chavali, V., Tyagi, S. C., & Mishra, P. K. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.07.105 · Cited by 70
Cysteine-674 oxidation and degradation of sarcoplasmic reticulum Ca2+ ATPase in diabetic pig aorta
Ying, J., Sharov, V. S., Xu, S., Jiang, B., Gerrity, R. G., Schöneich, C., & Cohen, R. A. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.05.029 · Cited by 70
Saddala, R. R., Thopireddy, L., Narasimhulu, G., & Kesireddy, S. R. (2011) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2011.05.003 · Cited by 70
Yu, X., Tesiram, Y. A., Towner, R. A., Abbott, A., Patterson, E. S., Huang, S., Garrett, M. W., Chandrasekaran, S., Matsuzaki, S., Szweda, L. I., et al. (2007) · Cardiovascular Diabetology · doi:10.1186/1475-2840-6-6 · Cited by 70
Tsuji, T., Mizushige, K., Noma, T., Murakami, K., Ohmori, K., Miyatake, A., & Kohno, M. (2001) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200112000-00008 · Cited by 70
The role of protein O-linked β-N-acetylglucosamine in mediating cardiac stress responses
Chatham, J. C., & Marchase, R. B. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.07.004 · Cited by 69
Mitochondrial Respiratory Impairment in Streptozotocin-Induced Diabetic Rat Heart
Tomita, M., Mukae, S., Geshi, E., Umetsu, K., Nakatani, M., & Katagiri, T. (1996) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.60.673 · Cited by 69
Hahn, N. E., Meischl, C., Kawahara, T., Musters, R. J. P., Verhoef, V. M. J., van der Velden, J., Vonk, A. B. A., Paulus, W. J., van Rossum, A. C., Niessen, H. W. M., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.02.018 · Cited by 67
Leptin’s regulation of obesity-induced cardiac extracellular matrix remodeling
Zibadi, S., Cordova-Marks, F. M., Slack, E. H., WATSON, R. R., & Larson, D. F. (2011) · Cardiovascular Toxicology · doi:10.1007/s12012-011-9124-0 · Cited by 67
Exercise Attenuates Diabetes-Induced Ultrastructural Changes in Rat Cardiac Tissue
Searls, Y. M., Smirnova, I. V., Fegley, B., & Stehno‐Bittel, L. (2004) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000145461.38224.ec · Cited by 66
Kelly, D. P. (2003) · Circulation Research · doi:10.1161/01.res.0000064382.46274.95 · Cited by 66
Heart Failure and Nephropathy: Catastrophic and Interrelated Complications of Diabetes
Gilbert, R. E., Connelly, K. A., Kelly, D. J., Pollock, C. A., & Krum, H. (2005) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00540705 · Cited by 66
Young, L. H., Balin, B. J., & Weis, M. T. (2006) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2005.tb00170.x · Cited by 65
Ca2+–Secretion Coupling Is Impaired in Diabetic Goto Kakizaki rats
Rose, T., Efendić, S., & Rupnik, M. S. (2007) · The Journal of General Physiology · doi:10.1085/jgp.200609604 · Cited by 65
Deficit of Coenzyme Q in Heart and Liver Mitochondria of Rats with Streptozotocin-Induced Diabetes
Kucharská, J., Braunová, Z., Uličná, O., Zlatoš, L., & Gvozdjáková, A. (2000) · Physiological Research · doi:10.33549/physiolres.930000.49.411 · Cited by 65
Iwata, M., Cowling, R. T., Yeo, S. J., & Greenberg, B. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.12.003 · Cited by 64
Angiotensin converting enzyme inhibitors and modulation of skeletal muscle insulin resistance
Henriksen, E. J., & Jacob, S. (2003) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2003.00265.x · Cited by 63
Kim, H. W., Cho, Y. S., Lee, H. R., Park, S. Y., & Kim, Y. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01483-7 · Cited by 63
Muraski, J. A., Fischer, K. M., Wu, W., Cottage, C. T., Quijada, P. J., Mason, M., Din, S., Gude, N. A., Alvarez, R., Rota, M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709135105 · Cited by 63
Bajraktari, G., Koltai, M. Z., Ademaj, F., Rexhepaj, N., Qirko, S., Ndrepepa, G., & Elezi, S. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.08.033 · Cited by 63
Mellor, K. M., Wendt, I. R., Ritchie, R. H., & Delbridge, L. M. D. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00797.2011 · Cited by 63
Self-citationLeft ventricle structural remodelling in the prediabetic Goto-Kakizaki rat
D’Souza, A., Howarth, F. C., Yanni, J., Dobrzynski, H., Boyett, M. R., Adeghate, E. A., Bidasee, K. R., & Singh, J. (2011) · Experimental Physiology · doi:10.1113/expphysiol.2011.058271 · Cited by 63
The Glucose/Insulin System and Vitamin C: Implications in Insulin-Dependent Diabetes Mellitus
Cunningham, J. J. (1998) · Journal of the American College of Nutrition · doi:10.1080/07315724.1998.10718734 · Cited by 62
Ritchie, R. H., Quinn, J. M. W., Cao, A., Drummond, G. R., Kaye, D. M., Favaloro, J. M., Proietto, J., & Delbridge, L. M. D. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.03.900 · Cited by 62
Self-citationCardiac Autophagy: Good With the Bad
Rifki, O. F., & Hill, J. A. (2012) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3182646cb1 · Cited by 62
Chrysohoou, C. A., Pitsavos, C., Barbetseas, J. D., Kotroyiannis, I., Brili, S. V., Vasiliadou, K., Papadimitriou, L., & Stefanadis, C. (2009) · Heart and Vessels · doi:10.1007/s00380-008-1080-7 · Cited by 61
Turdi, S., Li, Q., Norby, F. L., & Ren, J. T. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.07.029 · Cited by 61
McQueen, A. P., Zhang, D., Hu, P., Swenson, L., Yang, Y., Zaha, V. G., Hoffman, J. L., Yun, U. J., Chakrabarti, G., & Wang, Z. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.07.017 · Cited by 61
Winterbone, M. S., Sampson, M., Saha, S., Hughes, J. C., & Hughes, D. A. (2007) · Cardiovascular Diabetology · doi:10.1186/1475-2840-6-8 · Cited by 61
Oxidative burden in prediabetic and diabetic individuals: evidence from plasma coenzyme Q10
Lim, S. C., Tan, H. H., Goh, S. K., Subramaniam, T., Sum, C. F., Tan, I. K., Lee, B. L., & Ong, C. N. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01996.x · Cited by 60
Hu, B. (2011) · Molecular Medicine Reports · doi:10.3892/mmr.2011.489 · Cited by 60
Daniels, A., Linz, D., van Bilsen, M., Rütten, H., Sadowski, T., Ruf, S. G., Juretschke, H., Neumann‐Haefelin, C., Munts, C., Vusse, G. J., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr166 · Cited by 60
Yu, X., Chen, H., Liang, J., Lin, Q., Tan, H., Fu, Y., Liu, X., Shan, Z., Li, X., Yang, H.-Z., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016239 · Cited by 60
Schrauwen‐Hinderling, V. B., Meex, R. C. R., Hesselink, M. K. C., van de Weijer, T., Leiner, T., Schär, M., Lamb, H. J., Wildberger, J. E., Glatz, J. F. C., Schrauwen, P., et al. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-47 · Cited by 60
Lima, V. V., Spitler, K. M., Choi, H., Webb, R. C., & Tostes, R. C. (2012) · Clinical Science · doi:10.1042/cs20110638 · Cited by 60
Ryu, M.-H., & Cha, Y. (2003) · BMB Reports · doi:10.5483/bmbrep.2003.36.3.312 · Cited by 60
Bradykinin Blocks Angiotensin II–Induced Hypertrophy in the Presence of Endothelial Cells
Ritchie, R. H., Marsh, J. D., Lancaster, W. D., Diglio, C. A., & SCHIEBINGER, R. J. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.39 · Cited by 59
Self-citationChess, D. J., Xu, W., Khairallah, R. J., O’Shea, K. M., Kop, W. J., Azimzadeh, A. M., & Stanley, W. C. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00563.2008 · Cited by 58
Duncan, J. G. (2011) · Pediatric Cardiology · doi:10.1007/s00246-011-9889-8 · Cited by 58
Exploiting cGMP-based therapies for the prevention of left ventricular hypertrophy: NO• and beyond
Ritchie, R. H., Irvine, J. C., Rosenkranz, A. C., Patel, R., Wendt, I. R., Horowitz, J. D., & Kemp‐Harper, B. K. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.08.001 · Cited by 58
Self-citationCARDIAC HYPERTROPHY, SUBSTRATE UTILIZATION AND METABOLIC REMODELLING: CAUSE OR EFFECT?
Ritchie, R. H., & Delbridge, L. M. D. (2006) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2006.04342.x · Cited by 58
Self-citationSakata, S., Lebeche, D., Sakata, Y., Sakata, N., Chemaly, E. R., Liang, L. F., Padmanabhan, P., Konishi, N., Takaki, M., del Monte, F., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.01.002 · Cited by 57
Ferreira, N. E., Omae, S. V., Pereira, A., Rodrigues, M. V., Miyakawa, A. A., Campos, L. C. G., Santos, P. C. J. L., Dallan, L. A., Martinez, T. L. D. R., Santos, R. D., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.12.009 · Cited by 57
Palmieri, V., Capaldo, B., Russo, C. A., Iaccarino, M., Pezzullo, S., Quintavalle, G., Minno, G. D., Riccardi, G., & Celentano, A. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.09.014 · Cited by 57
Dutta, K., Carmody, M. W., Cala, S. E., & Davidoff, A. J. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.2035 · Cited by 57
Cardiac dysfunction in the Goto-Kakizaki rat
El‐Omar, M., Yang, Z., Phillips, A. O., et al. (2004) · Basic Research in Cardiology · doi:10.1007/s00395-004-0440-4 · Cited by 57
Epp, R., Susser, S. E., Morissette, M., Kehler, D. S., Jassal, D. S., & Duhamel, T. A. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2012-0294 · Cited by 56
Protein O-GlcNAcylation: A Critical Regulator of the Cellular Response to Stress
Chatham, J. C., & Marchase, R. B. (2010) · Current Signal Transduction Therapy · doi:10.2174/157436210790226492 · Cited by 55
Essential Hypertension Is Associated With Decreased Insulin Clearance and Insulin Resistance
Lender, D., Arauz-Pacheco, C., ADAMS-HUET, B. A., & Raskin, P. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.111 · Cited by 55
Thioredoxin1 as a Negative Regulator of Cardiac Hypertrophy
Ago, T., & Sadoshima, J. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1529 · Cited by 54
Predictors of insulin sensitivity in Type 2 diabetes mellitus
Bonora, E., Targher, G., Alberiche, M., Formentini, G., Calcaterra, F., Lombardi, S., Marini, F., Poli, M., Zenari, L., Raffaelli, A., et al. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00764.x · Cited by 54
Elangovan, V., Shohami, E., Gati, I., & Kohen, R. (2000) · Free Radical Research · doi:10.1080/10715760000300131 · Cited by 54
Kaczmarczyk, S. J., Andrikopoulos, S., Favaloro, J. M., Domenighetti, A. A., Dunn, A. R., Ernst, M., Grail, D., Fodero‐Tavoletti, M. T., Huggins, C. E., Delbridge, L., et al. (2003) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0310449 · Cited by 54
Luan, R., Liu, S., Yin, T., Lau, W. B., Wang, Q., Guo, W., Wang, H., & Tao, L. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp085 · Cited by 54
Cooksey, R. C., & McClain, D. A. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04268.x · Cited by 53
Singh, R. B., & Niaz, M. A. (1999) · International Journal of Cardiology · doi:10.1016/s0167-5273(98)00323-4 · Cited by 52
Giles, T. D., Ouyang, J., Kerut, E. K., Given, M. B., Allen, G., McIlwain, E., & Greenberg, S. S. (1998) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1998.274.1.h295 · Cited by 52
Altered calcium handling is an early sign of streptozotocin-induced diabetic cardiomyopathy
Ligeti, L., Szenczi, O., Prestia, C. M., et al. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.17.6.1035 · Cited by 52
Sağlam, A. S. Y., Menevşe, S., & Alp, E. (2011) · Genetics and Molecular Research · doi:10.4238/2011.november.29.7 · Cited by 51
Mechanisms of subcellular remodeling in heart failure due to diabetes
Dhalla, N. S., Takeda, N., Rodriguez–Leyva, D., & Elimban, V. (2013) · Heart Failure Reviews · doi:10.1007/s10741-013-9385-8 · Cited by 51
Rosiglitazone (Avandia) and pioglitazone (Actos) and heart failure.
Wooltorton, E. (2002) · PubMed Central · Cited by 50
Dingar, D. D., Merlen, C., Grandy, S. A., Gillis, M., Villeneuve, L. R., Mamarbachi, A. M., Fiset, C., & Allen, B. G. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.06.002 · Cited by 50
Craven, P. A., Phillips, S. L., Melhem, M. F., Liachenko, J., & DeRubertis, F. R. (2001) · Metabolism · doi:10.1053/meta.2001.25802 · Cited by 49
Lin, E., Irvine, J. C., Cao, A. H., Alexander, A. E., Love, J. E., Patel, R., McMullen, J. R., Kaye, D. M., Kemp‐Harper, B. K., & Ritchie, R. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034892 · Cited by 49
Self-citationLoganathan, R., Bilgen, M., Al‐Hafez, B., Zhero, S. V., Alenezy, M. D., & Smirnova, I. V. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00521.2006 · Cited by 48
Baynes, J., & Murray, D. B. (2009) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.2.5.9831 · Cited by 47
Wurm, S., Neumeier, M., Weigert, J., Schäffler, A., & Buechler, C. (2007) · Cardiovascular Diabetology · doi:10.1186/1475-2840-6-7 · Cited by 46
Hopkins, T. A., Sugden, M. C., Holness, M. J., Kozak, R., Dyck, J. R. B., & Lopaschuk, G. D. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00852.2002 · Cited by 46
Protein Kinase C-theta Inhibitors: A Novel Therapy for Inflammatory Disorders
Chand, S., Mehta, N., Bahia, M. S., Dixit, A., & Silakari, O. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802651625 · Cited by 46
Elevated dietary sugar and the heart: experimental models and myocardial remodeling
Mellor, K. M., Ritchie, R. H., Davidoff, A. J., & Delbridge, L. M. D. (2010) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y10-005 · Cited by 45
Self-citationInteracting with Thioredoxin-1—Disease or No Disease?
Zschauer, T.-C., Matsushima, S., Altschmied, J., Shao, D., Sadoshima, J., & Haendeler, J. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4822 · Cited by 45
von Bibra, H., Diamant, M., Scheffer, P. G., Siegmund, T., & Schumm‐Draeger, P. (2008) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2008.045 · Cited by 45
NADPH oxidase contributes to coronary endothelial dysfunction in the failing heart
Zhang, P., Hou, M., Li, Y., Xu, X., Barsoum, M. K., Chen, Y., & Bache, R. J. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00519.2008 · Cited by 45
Angiotensin converting enzyme inhibitors and cardiovascular remodelling
Vaughan, D. E., & Pfeffer, M. A. (1994) · Cardiovascular Research · doi:10.1093/cvr/28.2.159 · Cited by 44
Yang, H., Fan, S.-R., Song, D.-P., Wang, Z., Ma, S., Li, S., Li, X., Xu, M., Xu, M., & Wang, X. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.1227 · Cited by 44
Wai, B., Kearney, L. G., Hare, D. L., Ord, M., Burrell, L. M., & Srivastava, P. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-14 · Cited by 43
Chalmers, J., Arima, H., Harrap, S., Touyz, R. M., & Park, J. B. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e32835f7eef · Cited by 43
Diastolic Heart Failure: Progress, Treatment Challenges, and Prevention
Wood, P., Piran, S., & Liu, P. P. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2011.02.008 · Cited by 42
Gurusamy, N., Watanabe, K., Ma, M., Zhang, S., Muslin, A. J., Kodama, M., & Aizawa, Y. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.06.023 · Cited by 41
Neurohormonal profile of patients with heart failure and diabetes
van der Horst, I. C. C., de Boer, R. A., Hillege, H. L., Boomsma, F., Voors, A. A., & van Veldhuisen, D. J. (2010) · Netherlands Heart Journal · doi:10.1007/bf03091760 · Cited by 41
High free fatty acids level related with cardiac dysfunction in obese rats
Sun, X., Pan, H., Tan, H., & Yu, Y. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.10.028 · Cited by 41
Overexpression of human GPX1 modifies Bax to Bcl-2 apoptotic ratio in human endothelial cells
Faucher, K., Rabinovitch-Chable, H., Cook‐Moreau, J., Barrière, G., Sturtz, F. G., & Rigaud, M. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-5075-8 · Cited by 41
LaRocca, T. J., Fabris, F., Chen, J., Benhayon, D. A., Zhang, S., McCollum, L. T., Schecter, A. D., Cheung, J. Y., Sobie, E. A., Hajjar, R. J., et al. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01198.2011 · Cited by 41
Meloni, M., Descamps, B., Caporali, A., Zentilin, L., Floris, I., Giacca, M., & Emanueli, C. (2011) · Diabetes · doi:10.2337/db11-0763 · Cited by 41
VASCULAR ANGIOTENSIN AT2RECEPTORS IN HYPERTENSION AND AGEING
Widdop, R. E., Vinh, A., Henrion, D., & Jones, E. S. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.04883.x · Cited by 40
Pierce, G. J., Maddaford, T. G., & Russell, J. C. (1997) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y97-027 · Cited by 39
Ruggenenti, P. L., Iliev, I. P., Costa, G. M., Parvanova, A. I., Perna, A., Giuliano, G. A., Motterlini, N., Ene‐Iordache, B., Remuzzi, G., & the BENEDICT Study Group (2008) · Diabetes Care · doi:10.2337/dc08-0371 · Cited by 39
Cooperation between proteolytic systems in cardiomyocyte recycling
Yamaguchi, O., Taneike, M., & Otsu, K. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs236 · Cited by 39
Dietary coenzyme Q10supplement renders swine hearts resistant to ischemia-reperfusion injury
Maulik, N., Yoshida, T., Engelman, R. M., Bagchi, D., Otani, H., & Das, D. K. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.278.4.h1084 · Cited by 39
The as-yet unfulfilled promise of p38 MAPK inhibitors
Sweeney, S. E. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.171 · Cited by 38
Tang, C., Naassan, A. E., Chamson-Reig, A., Koulajian, K., Goh, T. T., Yoon, F. H., Oprescu, A. I., Ghanim, H., Lewis, G. F., Dandona, P., et al. (2012) · Endocrinology · doi:10.1210/en.2012-1720 · Cited by 38
Sabino, B. D., Lessa, M. A., do Nascimento, A. R., Rodrigues, C. A., Henriques, M. D. G., Garzoni, L. R., Levy, B. I., & Tibiriçá, E. V. (2008) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181673bc5 · Cited by 38
Nikoshkov, A., Sunkari, V. G., Savu, O., Forsberg, E., Catrina, S., & Brismar, K. (2011) · Epigenetics · doi:10.4161/epi.6.4.14791 · Cited by 37
Angiotensin (1-7) and other Angiotensin Peptides
Ohishi, M., Yamamoto, K. I., & Rakugi, H. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319170013 · Cited by 37
Li, D.-Y., Yang, B.-C., & Mehta, J. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00342-3 · Cited by 36
Song, Y., Du, Y., Prabhu, S. D., & Epstein, P. N. (2007) · The Review of Diabetic Studies · doi:10.1900/rds.2007.4.159 · Cited by 35
Liang, J., Xiao, D., Liu, X., Lin, Q., Shan, Z., Zhu, J.-N., Lin, S., & Yu, X. (2010) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2010.05420.x · Cited by 35
Ahmarani, L., Avedanian, L., Al-Khoury, J., Perreault, C., Jacques, D., & Bkaily, G. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2012-0265 · Cited by 35
Protein Kinases as Drug Development Targets for Heart Disease Therapy
Dhalla, N. S., & Muller, A. L. (2010) · Pharmaceuticals · doi:10.3390/ph3072111 · Cited by 34
A PKC-β inhibitor treatment reverses cardiac microvascular barrier dysfunction in diabetic rats
Wei, L., Yin, Z., Yuan, Y., Hwang, A., Lee, A. S., Sun, D., Li, F., Di, C., Zhang, R., Cao, F., et al. (2010) · Microvascular Research · doi:10.1016/j.mvr.2010.01.003 · Cited by 34
Sander, G. E., McKinnie, J. J., Greenberg, S. S., & Giles, T. D. (1999) · Progress in Cardiovascular Diseases · doi:10.1053/pcad.1999.0410265 · Cited by 34
SERCA overexpression reduces hydroxyl radical injury in murine myocardium
Hiranandani, N., Bupha‐Intr, T., & Janssen, P. M. L. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01315.2005 · Cited by 33
Cardiac dysfunction in isolated perfused hearts from spontaneously diabetic BB rats
Rodrigues, B. B., & McNeill, J. H. (1990) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y90-073 · Cited by 32
Ghattas, M. H., & Abo–Elmatty, D. M. (2012) · DNA and Cell Biology · doi:10.1089/dna.2012.1739 · Cited by 32
Arterial stiffening and cardiac hypertrophy in a new rat model of type 2 diabetes
Chang, K., Tseng, C. D., Chou, T., et al. (2005) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01588.x · Cited by 32
Beta-Blockers and Diabetes: The Bad Guys Come Good
Cruickshank, J. M. (2002) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1022146721098 · Cited by 31
Nosadini, R., & Tonolo, G. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000034687.62568.9b · Cited by 31
Mast cells and vascular diseases
Kennedy, S., Wu, J., Wadsworth, R. M., Lawrence, C. E., & Maffia, P. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.001 · Cited by 30
Hypertension and Diabetes—A Toxic Combination
Bell, D. S. H. (2008) · Endocrine Practice · doi:10.4158/ep.14.8.1031 · Cited by 30
Left Ventricular Diastolic Dysfunction Secondary to Hyperglycemia in Patients with Type II Diabetes
Sánchez‐Barriga, J. J., Rangel, A., Limones, R. C., Flores, D. H., Frati, A., Ramos, M. A., & Amato, D. (2001) · Archives of Medical Research · doi:10.1016/s0188-4409(00)00264-2 · Cited by 30
Ferko, M., Gvozdjáková, A., Kucharská, J., Mujkošová, J., Waczulíková, I., Styk, J., Ravíngerová, T., Ziegelhöffer‐Mihalovičová, B., & Ziegelhöffer, A. (2006) · PubMed · Cited by 30
Application of recombinant thioredoxin1 for treatment of heart disease
Matsushima, S., Zablocki, D., & Sadoshima, J. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.09.020 · Cited by 29
Kohlhaas, M., & Maack, C. (2011) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2012.03.002 · Cited by 29
Antioxidant Vitamins in the Prevention of Atrial Fibrillation: What Is the Evidence?
Rasoli, S., Kakouros, N., Harling, L., Gukop, P. S., Soni, M., Athanasiou, T., & Kourliouros, A. (2011) · Cardiology Research and Practice · doi:10.4061/2011/164078 · Cited by 28
Are Physicians Aware of the Side Effects of Angiotensin-Converting Enzyme Inhibitors?
Lombardi, C., Crivellaro, M., Dama, A., Senna, G., Gargioni, S., & Passalacqua, G. (2005) · CHEST Journal · doi:10.1378/chest.128.2.976 · Cited by 28
Ritchie, R. H., Leo, C. H., Qin, C. X., Stephenson, E. J., Bowden, M. A., Buxton, K. D., Lessard, S. J., Rivas, D. A., Koch, L. G., Britton, S. L., et al. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00638.2012 · Cited by 27
Self-citationAllemann, S., Diem, P., Egger, M., Christ, E., & Stettler, C. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x89865 · Cited by 26
Nakayama, H., Morozumi, T., Nanto, S., Shimonagata, T., Ohara, T., 鷹野, 譲., Kotani, J., Watanabe, T., Fujita, M., Nishio, M., et al. (2001) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.65.783 · Cited by 26
Mitogen-activated protein kinases in the acute diabetic myocardium
Strnisková, M., Barančík, M., Neckář, J., & Ravíngerová, T. (2003) · Springer eBooks · doi:10.1007/978-1-4419-9236-9_8 · Cited by 25
Diabetic cardiac autonomic neuropathy: Insights from animal models
Stables, C. L., Glasser, R., & Feldman, E. L. (2013) · Autonomic Neuroscience · doi:10.1016/j.autneu.2013.03.001 · Cited by 25
Emerging treatments for the prevention of type 1 diabetes
Raskin, P., & Mohan, A. (2010) · Expert Opinion on Emerging Drugs · doi:10.1517/14728211003694631 · Cited by 25
Mitogen-activated protein kinases in the acute diabetic myocardium
Strnisková, M., Barančík, M., Neckář, J., & Ravíngerová, T. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1024774303744 · Cited by 24
O-GlcNAcylation, an original modulator of contractile activity in striated muscle
Cieniewski‐Bernard, C., Montel, V., Stevens, L., & Bastide, B. (2009) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-010-9201-1 · Cited by 23
Diniz, Y. S., Santos, D., Assalin, H. B., Souza, G. A., Rocha, K. K. H. R., Ebaid, G. M. X., Seiva, F. R. F., Amauchi, J. F., Filho, J. L. V. B. N., & Novelli, E. L. B. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.008 · Cited by 23
Liu, J., Zhou, J., An, W., Lin, Y., Yang, Y.-B., & Zang, W. (2010) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y10-063 · Cited by 23
Yong, T. Y., Phillipov, G., & Phillips, P. J. J. (2007) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2007.tb01078.x · Cited by 23
Lipid-lowering therapy in people with type 2 diabetes
Colagiuri, S., & Best, J. D. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200212000-00004 · Cited by 22
Verbesserung der Myokardfunktion durch verbesserte Stoffwechselkontrolle bei Typ-2-Diabetes
von Bibra, H., Siegmund, T., Hansen, A. E., Jensen, J., & Schumm‐Draeger, P. ‐. (2007) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-2007-973608 · Cited by 21
Reid, C. M. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(03)00110-9 · Cited by 20
Davidoff, A. J. (2006) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2006.04343.x · Cited by 20
The cardioprotective role of beta-blockers in patients with diabetes mellitus
Landray, M., Toescu, V., & Kendall, M. J. (2002) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2002.00419.x · Cited by 20
Insulin resistance and the effects of thiazolidinediones on cardiac metabolism
Young, L. H. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.09.013 · Cited by 19
Weber, C. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300920 · Cited by 19
Use of Beta Blockers in the Patient With Diabetes
Bell, D. S. H. (2003) · The Endocrinologist · doi:10.1097/01.ten.0000076214.95014.05 · Cited by 19
Structural and functional changes in heart mitochondria from sucrose-fed hypertriglyceridemic rats
Carvajal, K., Hafidi, M. E., Marín‐Hernández, Á., & Moreno‐Sánchez, R. (2005) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2005.08.001 · Cited by 17
Hiller, K., Ruile, P., Kraus, G., et al. (2010) · Microvascular Research · doi:10.1016/j.mvr.2010.05.007 · Cited by 16
Gagnon, C., Legault, F., Geraldes, P., Tanguay, J., & Lambert, C. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.10.016 · Cited by 16
Atrial natriuretic peptide prevents diabetes-induced endothelial dysfunction
Woodman, O. L., Malakul, W., Cao, A. H., Xu, Q., & Ritchie, R. H. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.01.016 · Cited by 16
Self-citationThe protective effects of exercise and phosphoinositide 3-kinase (p110α) in the failing heart
Owen, K., Pretorius, L., & McMullen, J. R. (2009) · Clinical Science · doi:10.1042/cs20080183 · Cited by 15
Self-citationChymase Inhibition and Cardiovascular Protection
Tojo, H., & Urata, H. (2013) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-013-6450-4 · Cited by 14
Ordu, S., Özhan, H., Alemdar, R., Aydın, M., Başar, C., Çağlar, O., Yazıcı, M., & Yalçin, S. (2010) · PubMed · doi:10.2143/ac.65.4.2053898 · Cited by 14
Sundaram, R., Rajendran, N. K., Shanthi, P., & Sachdanandam, P. (2012) · Process Biochemistry · doi:10.1016/j.procbio.2012.07.025 · Cited by 12
New Adeno-Associated Virus Strategies to Support Momentum in the Clinic
Wright, J. F. (2011) · Human Gene Therapy · doi:10.1089/hum.2011.4080 · Cited by 10
Vitamin E supplementation: what's the harm in that?
Miller, E. R., & Güallar, E. (2009) · Clinical Trials · doi:10.1177/1740774509103248 · Cited by 10
Sun, Z., & Ernsberger, P. R. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.111153 · Cited by 9
Wild, S. H., & Byrne, C. D. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.1424-5.x · Cited by 9
Endothelin-1 Release and Stimulation of the Inflammatory Cascade
Davidson, K. W., Burg, M. M., & Shimbo, D. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.08.079 · Cited by 5
Howarth, F. C., Qureshi, M. A., Hassan, Z. A., Kury, L. A., Isaev, D. S., Parekh, K. A., Yammahi, S. R. R. K. D., John, A., Öz, M., Raza, H., et al. (2012) · Hamdan Medical Journal · doi:10.7707/hmj.v5i2.140 · Cited by 4
Thioredoxin in the Cardiovascular System—Towards a Thioredoxin-Based Antioxidative Therapy
WORLD, C., & Berk, B. C. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-600-9_26 · Cited by 1
Cited by
Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity
Jia, G., Hill, M. A., & Sowers, J. R. (2018) · Circulation Research · doi:10.1161/circresaha.117.311586 · Cited by 1,807
Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
Forrester, S. J., Booz, G. W., Sigmund, C. D., Coffman, T. M., Kawai, T., Rizzo, V., Scalia, R., & Eguchi, S. (2018) · Physiological Reviews · doi:10.1152/physrev.00038.2017 · Cited by 1,095
Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy
Jia, G., DeMarco, V. G., & Sowers, J. R. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.216 · Cited by 949
Tham, Y. K., Bernardo, B. C., Ooi, J. Y. Y., Weeks, K. L., & McMullen, J. R. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1477-x · Cited by 708
Self-citationBasic Mechanisms of Diabetic Heart Disease
Ritchie, R. H., & Abel, E. D. (2020) · Circulation Research · doi:10.1161/circresaha.120.315913 · Cited by 708
Self-citation
Metadata
- Authors
- Huynh, K., Bernardo, B. C., McMullen, J. R., & Ritchie, R. H.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2014-06
- Volume
- 142
- Issue
- 3
- Pages
- 375-415
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2104044832
- Cited by
- 553
- References
- 768
- FWCI
- 28.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.